CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Open-market buy Director bought 3,250 shares at $4.00 ($13,000)
- 4 Open-market buy Chief Scientific Officer bought 1,000 shares at $4.00 ($4,000)
- 4 Open-market buy Director bought 6,250 shares at $4.00 ($25,000)
- 4 Open-market buy President and CEO bought 5,000 shares at $4.00 ($20,000)
- 4 Open-market buy Director bought 2,250 shares at $4.00 ($9,000)
- 4 Open-market buy CFO and Secretary bought 1,250 shares at $4.00 ($5,000)
- 4 Open-market buy Director bought 11,250 shares at $4.00 ($45,000)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $4.00 ($4,000)
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B4 Offering Prospectus
- CT ORDER Other Confidential Order
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 20 of 22 · 427 filings